Ignite Creation Date:
2024-05-06 @ 3:12 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04550624
Status:
RECRUITING
Last Update Posted:
2024-01-19
First Post:
2020-08-31
Brief Title:
Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma
Sponsor:
Organization:
Shanghai Jiahui International Hospital